Travel in the Tropics and Acquisition of Multidrug-resistant Bacteria (VOYAG-R)

FMT for Multidrug Resistant Organism Reversal

NCT02312986 ·Status: COMPLETED ·Phase: PHASE1

Infection Risk Associated With Digestive MDRO Carriage in Hospitalized Patients

NCT07134270 ·Status: RECRUITING

Fecal Microbiota Transplantation for Decolonization of Multidrug-resistant Microorganisms

NCT07265817 ·Status: NOT_YET_RECRUITING ·Phase: NA

Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence

NCT05266807 ·Status: RECRUITING ·Phase: PHASE3

Phase II Trial of Fecal Microbiota Transplant (FMT) for VRE and CRE Patients

NCT03643887 ·Status: WITHDRAWN ·Phase: PHASE2

Bioequivalence Study - Reference Clinical Fexinidazole Tablet Versus Proposed Market Formulation

NCT02571062 ·Status: COMPLETED ·Phase: PHASE1

Impact of Probiotic Regimen on Vancomycin Resistant Enterococcus Intestinal Carriage

NCT00437580 ·Status: UNKNOWN ·Phase: PHASE4

Microbiome Changes in Travelers to Tropical Destinations

NCT02295254 ·Status: UNKNOWN

Primary or Recurrent Clostridioides Difficile Infection Treatment With Capsules of Lyophilised Faecal Microbiota vs Fidaxomicin

NCT05201079 ·Status: COMPLETED ·Phase: PHASE3

Rectal Bacteriotherapy, Fecal Microbiota Transplantation or Oral Vancomycin Treatment of Recurrent Clostridium Difficile Infections

NCT02774382 ·Status: UNKNOWN ·Phase: PHASE3

Safety of Stool Transplant for Patients With Difficult to Treat C. Difficile Infection

NCT02770326 ·Status: COMPLETED ·Phase: NA

Safety, Tolerability, and Immunogenicity Study of a Clostridium Difficile Toxoid Vaccine in Healthy Adult Volunteers

NCT00127803 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of Oral Administration of the Phage Cocktail, VRELysin™, In Healthy and VRE-Colonized Subjects

NCT05715619 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2

Fecal Microbiota Transplantation for Severe Clostridium Difficile Infection

NCT03427229 ·Status: COMPLETED ·Phase: PHASE2

Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics

NCT07261826 ·Status: RECRUITING

Prophylactic Treatment of Travellers' Diarrhoea With Rifaximin

NCT00979056 ·Status: COMPLETED ·Phase: PHASE3

Characterization of Fecal Microbiota in a Population Aged 50 to 75 Years Targeted by Seasonal Vaccination

NCT05972590 ·Status: COMPLETED ·Phase: NA

A Study To Investigate Two 3-dose Schedules Of A Clostridium Difficile Vaccine In Healthy Adults Aged 65 to 85 Years

NCT02561195 ·Status: COMPLETED ·Phase: PHASE2

FEcal Transplant, a Hope to Eradicate Colonization of Patient Harboring eXtreme Drug Resistant Bacteria?

NCT03029078 ·Status: COMPLETED ·Phase: PHASE4

C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.

NCT07250724 ·Status: RECRUITING

Safety Study of Recombinant Vaccine to Prevent ETEC Diarrhea

NCT01382095 ·Status: COMPLETED ·Phase: PHASE1

Bacillus Velezensis DSM 33864 for Reduction of the Risk of Recurrent Clostridioides Difficile Infections

NCT05606159 ·Status: WITHDRAWN ·Phase: NA

Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Via Capsules for Intestinal Multidrug-resistant Bacteria Decolonization

NCT07106580 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Fecal Microbiota Transplantation for Treatment of Gastrointestinal Dysbiosis or Clearance of ARO

NCT03834051 ·Status: TERMINATED ·Phase: NA

Study to Collect Information About Invasive Disease Caused by Extraintestinal Pathogenic Escherichia Coli (EXPECT-1)

NCT04087681 ·Status: COMPLETED